A multiomics signature highlights alterations underlying homologous recombination deficiency in triple-negative breast cancer
Chao You(Fudan University Shanghai Cancer Center), Yajia Gu(Fudan University Shanghai Cancer Center), Yi‐Zhou Jiang(Shanghai Medical College of Fudan University), Zhi‐Ming Shao(Fudan University Shanghai Cancer Center), He Wang(Shanghai Center for Brain Science and Brain-Inspired Technology), Weijun Peng(Fudan University Shanghai Cancer Center), Yi Xiao(Fudan University Shanghai Cancer Center), Rencheng Zheng(Shanghai Center for Brain Science and Brain-Inspired Technology), Lin Jiang(Fudan University Shanghai Cancer Center), Guan-Hua Su(Fudan University Shanghai Cancer Center)
Cited by 0
Related Papers
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
|Cell Research|2022|315
Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
|Signal Transduction and Targeted Therapy|2024|187
Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients
|Nature Communications|2018|183
Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence
|Signal Transduction and Targeted Therapy|2021|171